Literature DB >> 18266495

Clinical and neural correlates of alexithymia in posttraumatic stress disorder.

Paul A Frewen1, Ruth A Lanius, David J A Dozois, Richard W J Neufeld, Clare Pain, James W Hopper, Maria Densmore, Todd K Stevens.   

Abstract

Individuals with posttraumatic stress disorder (PTSD) often exhibit deficits in emotional experience and expression, which suggests that certain individuals with PTSD may be alexithymic. In this study, in a sample of 105 individuals with PTSD, clinical correlates of alexithymia included reexperiencing, hyperarousal, numbing, dissociative symptoms, and retrospectively reported experiences of childhood emotional neglect. In a subsample of 26 individuals with PTSD related to a motor vehicle accident, functional neural responses to trauma-script imagery were associated with severity of alexithymia, including increased right posterior-insula and ventral posterior-cingulate activation and decreased bilateral ventral anterior-cingulate, ventromedial prefrontal, anterior-insula, and right inferior frontal cortex activation. Clinical and theoretical implications and future research directions are discussed. (c) 2008 APA, all rights reserved

Entities:  

Mesh:

Year:  2008        PMID: 18266495     DOI: 10.1037/0021-843X.117.1.171

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  36 in total

1.  Violence-related PTSD and neural activation when seeing emotionally charged male-female interactions.

Authors:  Dominik A Moser; Tatjana Aue; Francesca Suardi; Hana Kutlikova; Maria I Cordero; Ana Sancho Rossignol; Nicolas Favez; Sandra Rusconi Serpa; Daniel S Schechter
Journal:  Soc Cogn Affect Neurosci       Date:  2014-07-25       Impact factor: 3.436

2.  Impact Statement Coding of Self-Related Thought in Women With Posttraumatic Stress Disorder.

Authors:  Carissa L Philippi; Gregory Dahl; Miranda Jany; Steven E Bruce
Journal:  J Trauma Stress       Date:  2019-03-20

3.  Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future study.

Authors:  Paul H Lysaker; Shirley M Glynn; Sandra M Wilkniss; Steven M Silverstein
Journal:  Psychol Serv       Date:  2010-05-01

4.  Error monitoring is related to processing internal affective states.

Authors:  Martin E Maier; Cristina Scarpazza; Francesca Starita; Roberto Filogamo; Elisabetta Làdavas
Journal:  Cogn Affect Behav Neurosci       Date:  2016-12       Impact factor: 3.282

5.  Emotional Clarity as a Mechanism Linking Emotional Neglect and Depressive Symptoms during Early Adolescence.

Authors:  Allison J Jessar; Jessica L Hamilton; Megan Flynn; Lyn Y Abramson; Lauren B Alloy
Journal:  J Early Adolesc       Date:  2015-10-11

6.  Insula's functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving.

Authors:  Matthew T Sutherland; Allison J Carroll; Betty Jo Salmeron; Thomas J Ross; Elliot A Stein
Journal:  Psychopharmacology (Berl)       Date:  2013-02-28       Impact factor: 4.530

7.  Alterations in default network connectivity in posttraumatic stress disorder related to early-life trauma.

Authors:  Robyn L Bluhm; Peter C Williamson; Elizabeth A Osuch; Paul A Frewen; Todd K Stevens; Kristine Boksman; Richard W J Neufeld; Jean Théberge; Ruth A Lanius
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

Review 8.  Conjoint activity of anterior insular and anterior cingulate cortex: awareness and response.

Authors:  Nick Medford; Hugo D Critchley
Journal:  Brain Struct Funct       Date:  2010-05-29       Impact factor: 3.270

9.  Alexithymia and posttraumatic stress disorder following asthma attack.

Authors:  Man Cheung Chung; Natalie Wall
Journal:  Psychiatr Q       Date:  2013-09

10.  The human mirror neuron system in a population with deficient self-awareness: an fMRI study in alexithymia.

Authors:  Yoshiya Moriguchi; Takashi Ohnishi; Jean Decety; Makiko Hirakata; Motonari Maeda; Hiroshi Matsuda; Gen Komaki
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.